Journal
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION
Volume 8, Issue 12, Pages 898-908Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jash.2014.09.020
Keywords
Health services; health insurance reimbursement; medicare; white coat hypertension
Categories
Funding
- National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH) [T32HL007457, P01HL047540, P01HL047540-19S1]
- Amgen Inc.
Ask authors/readers for more resources
Ambulatory blood pressure monitoring (ABPM) can be used to identify white coat hypertension and guide hypertensive treatment. We determined the percentage of ABPM claims submitted between 2007 and 2010 that were reimbursed. Among 1970 Medicare beneficiaries with submitted claims, ABPM was reimbursed for 93.8% of claims that had an International Classification of Diseases, Ninth Revision, diagnosis code of 796.2 (elevated blood pressure reading without diagnosis of hypertension) versus 28.5% of claims without this code. Among claims without an International Classification of Diseases, Ninth Revision, diagnosis code of 796.2 listed, those for the component (eg, recording, scanning analysis, physician review, reporting) versus full ABPM procedures and performed by institutional versus non institutional providers were each more than two times as likely to be successfully reimbursed. Of the claims reimbursed, the median payment was $52.01 (25th-75th percentiles, $32.95-$64.98). In conclusion, educating providers on the ABPM claims reimbursement process and evaluation of Medicare reimbursement may increase the appropriate use of ABPM and improve patient care. (C) 2014 American Society of Hypertension. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available